BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37755325)

  • 1. Pathogenomics model for personalized medicine in cervical cancer: Cross-talk of gene expressions and pathological images related to oxidative stress.
    Li J; Chen S; Wu J; Liu X; Liu H; Liu Y; Zhu Z
    Environ Toxicol; 2024 Feb; 39(2):751-767. PubMed ID: 37755325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating subtypes of lung adenocarcinoma by oxidative stress and immunotherapy related genes.
    Duan G; Huang C; Zhao J; Zhang Y; Zhao W; Dai H
    Sci Rep; 2023 Nov; 13(1):20930. PubMed ID: 38017020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive study of oxidative stress-related effects on the prognosis and drug therapy of cervical cancer.
    Sheng N; He C; Jin X; Meng Q; Gu P; Ding S; Liu H; Xu Y
    J Gene Med; 2024 Jan; 26(1):e3581. PubMed ID: 37605936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterizing the key genes of COVID-19 that regulate tumor immune microenvironment and prognosis in hepatocellular carcinoma.
    Gao S; Zhang L; Wang H
    Funct Integr Genomics; 2023 Aug; 23(3):262. PubMed ID: 37540264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and Validation of Invasion-Related Molecular Subtypes and Prognostic Features for Cervical Cancer.
    Wang X; Wang J; Yu M
    Comput Math Methods Med; 2022; 2022():1902289. PubMed ID: 35345518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction and validation of a bladder cancer risk model based on autophagy-related genes.
    Shen C; Yan Y; Yang S; Wang Z; Wu Z; Li Z; Zhang Z; Lin Y; Li P; Hu H
    Funct Integr Genomics; 2023 Jan; 23(1):46. PubMed ID: 36689018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of immune related molecular subtypes and prognosis model for predicting prognosis, drug resistance in cervical squamous cell carcinoma.
    Hu D; Zhang Z; Zhang Y; Huang K; Li X
    Front Genet; 2023; 14():1137995. PubMed ID: 37007965
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification of copper metabolism and cuproptosis-related subtypes for predicting prognosis tumor microenvironment and drug candidates in hepatocellular carcinoma.
    Liu X; Sun B; Yao Y; Lai L; Wang X; Xiong J; Zhang X; Jiang J
    Front Immunol; 2022; 13():996308. PubMed ID: 36275743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cuproptosis-Related Signature Predicts the Prognosis, Tumor Microenvironment, and Drug Sensitivity of Hepatocellular Carcinoma.
    Qi X; Guo J; Chen G; Fang C; Hu L; Li J; Zhang C
    J Immunol Res; 2022; 2022():3393027. PubMed ID: 36438201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of stem cell landscape and identification of stemness-relevant prognostic gene signature to aid immunotherapy in colorectal cancer.
    Zheng H; Liu H; Li H; Dou W; Wang J; Zhang J; Liu T; Wu Y; Liu Y; Wang X
    Stem Cell Res Ther; 2022 Jun; 13(1):244. PubMed ID: 35681225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Oxidative Stress-Associated Molecular Subtypes and Signature for Predicting Survival Outcome of Cervical Squamous Cell Carcinoma.
    Wang L; Qu H; Ma X; Liu X
    Oxid Med Cell Longev; 2022; 2022():1056825. PubMed ID: 36225179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Prognostic Features of Hepatocellular Carcinoma Based on Metabolic Gene Classification and Immune and Oxidative Stress Characteristic Analysis.
    Cui S; Zhang M; Bai S; Bi Y; Cong S; Jin S; Li S; He H; Zhang J
    Oxid Med Cell Longev; 2023; 2023():1847700. PubMed ID: 36860731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Validation of a Novel Gene Signature for Predicting the Prognosis by Identifying m5C Modification Subtypes of Cervical Cancer.
    Yu J; Liang LL; Liu J; Liu TT; Li J; Xiu L; Zeng J; Wang TT; Wang D; Liang LJ; Xie DW; Chen DX; An JS; Wu LY
    Front Genet; 2021; 12():733715. PubMed ID: 34630524
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
    Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
    Front Genet; 2022; 13():919389. PubMed ID: 35783281
    [No Abstract]   [Full Text] [Related]  

  • 16. Multiomics analysis of ferroptosis-related molecular subtypes in muscle-invasive bladder cancer immunotherapy.
    Wang H; Dai Y; Wu X; Hu B; Wang Z; Yan M
    Transl Cancer Res; 2022 Nov; 11(11):4089-4104. PubMed ID: 36523302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune-Related Gene-Based Novel Subtypes to Establish a Model Predicting the Risk of Prostate Cancer.
    Zhang E; He J; Zhang H; Shan L; Wu H; Zhang M; Song Y
    Front Genet; 2020; 11():595657. PubMed ID: 33281882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multi-omics-based investigation of the prognostic and immunological impact of necroptosis-related mRNA in patients with cervical squamous carcinoma and adenocarcinoma.
    Zou J; Lin Z; Jiao W; Chen J; Lin L; Zhang F; Zhang X; Zhao J
    Sci Rep; 2022 Oct; 12(1):16773. PubMed ID: 36202899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor microenvironment characterization in cervical cancer identifies prognostic relevant gene signatures.
    Peng L; Hayatullah G; Zhou H; Chang S; Liu L; Qiu H; Duan X; Han L
    PLoS One; 2021; 16(4):e0249374. PubMed ID: 33901225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three Immune-Associated Subtypes of Diffuse Glioma Differ in Immune Infiltration, Immune Checkpoint Molecules, and Prognosis.
    Zhou Q; Yan X; Liu W; Yin W; Xu H; Cheng D; Jiang X; Ren C
    Front Oncol; 2020; 10():586019. PubMed ID: 33425739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.